0001062993-21-008352.txt : 20210908
0001062993-21-008352.hdr.sgml : 20210908
20210908120643
ACCESSION NUMBER: 0001062993-21-008352
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210903
FILED AS OF DATE: 20210908
DATE AS OF CHANGE: 20210908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TUMOLO ANNETTE
CENTRAL INDEX KEY: 0001717996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07928
FILM NUMBER: 211241275
MAIL ADDRESS:
STREET 1: C/O BIO-RAD LABORATORIES, INC.
STREET 2: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-RAD LABORATORIES, INC.
CENTRAL INDEX KEY: 0000012208
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 941381833
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
BUSINESS PHONE: 5107247000
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
FORMER COMPANY:
FORMER CONFORMED NAME: BIO RAD LABORATORIES INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2021-09-03
0000012208
BIO-RAD LABORATORIES, INC.
BIO BIOB
0001717996
TUMOLO ANNETTE
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES
CA
94547
0
1
0
0
Executive Vice President
Bio-Rad A Common Stock
2021-09-03
4
M
0
557
.00
A
3939.3476
D
Bio-Rad A Common Stock
2021-09-03
4
F
0
252
819.70
D
3687.3476
D
Bio-Rad A Common Stock
2021-09-04
4
M
0
600
.00
A
4287.3476
D
Bio-Rad A Common Stock
2021-09-04
4
F
0
298
819.70
D
3989.3476
D
Bio-Rad A Common Stock
2021-09-05
4
M
0
600
.00
A
4589.3476
D
Bio-Rad A Common Stock
2021-09-05
4
F
0
298
819.70
D
4291.3476
D
Restricted Stock Units
0
2021-09-03
4
M
0
557
0
D
Bio-Rad A Common Stock
557
1671
D
Restricted Stock Units
0
2021-09-04
4
M
0
600
0
D
Bio-Rad A Common Stock
600
1200
D
Restricted Stock Units
0
2021-09-05
4
M
0
600
0
D
Bio-Rad A Common Stock
600
600
D
Shares of Class A common stock acquired on the vesting of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
/s/ Annette Tumolo
2021-09-07